S4
(CH, Ar), 129.0 (CH, Ar), 128.7 (CH, Ar), 127.8 (CH, Ar), 96. 
Cbz-L-Thr-D-Val-L-Val-D-allo-Thr(tert-butyl)-D-Asn(Trt)-L-Ala-OH (9)
The hexapeptide 9 was synthesized by following the general method for solid-phase peptide synthesis on 0.20 mmol scale. The peptide was cleaved from the resin by agitating with (4:1 CH 2 Cl 2 /1,1,1,3,3,3-hexafluoro-2-propanol) (3 × 5 mL) for 20 min. The solvent was removed under reduced pressure and the residue azeotropically distilled with toluene (3 × 30 mL). The residue was then purified by preparative RP-HPLC under the standard conditions. This afforded 9 as an amorphous colourless solid (0.19 g, 90%, based on estimated loading of L-Ala resin of 0.8 mmol/g); 
15-Hydroxypentadecanoic acid
Pentadecanolide (5.0 g, 21 mmol) was dissolved in a 1:1 solution of methanol/THF (20 mL). To this solution was added NaOH (7.7 g, 0.19 mol) dissolved in H 2 O (10 mL). The reaction mixture was stirred overnight before being partitioned between 3:1 chloroform/isopropanol (50 mL) and 1 M HCl (50 mL). The aqueous fraction was extracted with 3:1 chloroform/isopropanol (3 × 50 mL).
The organic fractions were then combined and dried (Na 2 SO 4 ), and the solvent was removed under reduced pressure. This afforded 15-hydroxypentadecanoic acid as a colourless solid (5.4 g, quant. 
1-Methyl-15-[bis(tert-Butoxycarbonyl)guanidino] pentadecanoate (15)
To a solution of 15-hydroxypentadecanoic acid (3.3 g, 13 mmol) in methanol (60 mL) was added acetyl chloride (3.0 mL, 39 mmol). This solution was heated under reflux for 16 h, then the solvent was then removed under reduced pressure and the residue azeotropically distilled with toluene (3 × 30 mL). The crude methyl ester 14 was then isolated as a white solid (3.5 g, 98%) and used without further purification.
Under an atmosphere of argon a solution of 14 (1.78 g, approx. 6.5 mmol), triphenylphosphine (3.4 g, 13 mmol) and 1-3-bis(tert-butoxycarbonyl) guanidine (2.6 g, 13 mmol) in THF (50 mL) was cooled to 0 °C then diisopropyl azodicarboxylate (2.6 mL, 13 mmol) was added dropwise. This solution was stirred for 16 h before the solvent was removed under reduced pressure. 
Cyclic depsipeptide (17)
Compound 8 (0.18 g, 0.18 mmol) was dissolved in 20 mL of dry THF, and Pd/C catalyst (10% w/w, 0.1 g) was added. The reaction flask was evacuated and purged with H 2 three times, and the solution was left under stirring in an atmosphere of H 2 for 24 h. More Pd/C catalyst (10% w/w, 50 mg) was then added and the solution was left under stirring in an atmosphere of H 2 for another 24 h. 
